Literature DB >> 9650580

2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms.

S Kondo1, H Kondo, S Nakane, T Kodaka, A Tokumura, K Waku, T Sugiura.   

Abstract

The molecular species compositions of monoacylglycerols obtained from various rat tissues were examined by reverse-phase high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) analyses. We confirmed that 2-arachidonoylglycerol, an endogenous cannabinoid receptor agonist, is one of the most abundant molecular species of monoacylglycerols in the brain. Substantial amounts of 2-arachidonoylglycerol were also found in the liver, spleen, lung and kidney, but the levels were considerably lower than that in the brain. We found that a small amount of 2-arachidonoylglycerol was generated in a brain homogenate during incubation in the absence of Ca2+. Importantly, the generation of 2-arachidonoylglycerol was markedly augmented in the presence of Ca2+, suggesting that Ca2+ plays a key role in regulation of the generation of 2-arachidonoylglycerol in this tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650580     DOI: 10.1016/s0014-5793(98)00581-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

Review 1.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

Review 2.  CB2 receptors as new therapeutic targets for liver diseases.

Authors:  S Lotersztajn; F Teixeira-Clerc; B Julien; V Deveaux; Y Ichigotani; S Manin; J Tran-Van-Nhieu; M Karsak; A Zimmer; A Mallat
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

3.  The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria.

Authors:  Patrizia Zaccagnino; Susanna D'Oria; Luigi Luciano Romano; Almerinda Di Venere; Anna Maria Sardanelli; Michele Lorusso
Journal:  J Bioenerg Biomembr       Date:  2012-03-22       Impact factor: 2.945

4.  Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.

Authors:  Claire L De-May; Afia B Ali
Journal:  J Neurophysiol       Date:  2012-10-10       Impact factor: 2.714

Review 5.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

Review 6.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons.

Authors:  John J Marshall; Jian Xu; Anis Contractor
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

8.  P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.

Authors:  Anke Witting; Lisa Walter; Jennifer Wacker; Thomas Möller; Nephi Stella
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

9.  Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity.

Authors:  S Shu-Jung Hu; H B Bradshaw; J S-C Chen; B Tan; J Michael Walker
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

10.  Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity.

Authors:  Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Eur J Immunol       Date:  2016-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.